Q32 Bio: Funding, Investors & Team (Sep 2026)
Q32 Bio is a biotechnology company focused on creating treatments for individuals suffering from severe autoimmune and inflammatory conditions. The company aims to bring relief to patients facing limited treatment options or inadequate therapeutic options by addressing dysregulation. The team at Q32 Bio is made up of experienced scientists and industry professionals with a deep knowledge of immunology, and a successful history of discovering and advancing novel therapies.
Q32 Bio has raised $168M across 4 funding rounds on record, the most recent an undisclosed round of $55.0M announced in May 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Q32 Bio Company Profile and Key Stats
Latest funding round on record: May 2026.
Q32 Bio Funding Rounds
Q32 Bio raised $60.0M in an undisclosed round announced in Oct 2020.
3.4 years later, an undisclosed round of $42.0M was announced in Mar 2024.
1.9 years later, an undisclosed round of $10.5M was announced in Feb 2026.
3 months later, an undisclosed round of $55.0M was announced in May 2026.
Q32 Bio Founders and Leadership Team
Contact details for the Q32 Bio team: 1 of 3 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Q32 Bio Funding Compared to Other Biotechnology Startups
Q32 Bio's latest round of $55.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Q32 Bio in Biotechnology and Cambridge
Companies Similar to Q32 Bio
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Q32 Bio Funding FAQs
What does Q32 Bio do?
Q32 Bio is a biotechnology company focused on creating treatments for individuals suffering from severe autoimmune and inflammatory conditions. The company aims to bring relief to patients facing limited treatment options or inadequate therapeutic options by addressing dysregulation. The team at Q32 Bio is made up of experienced scientists and industry professionals with a deep knowledge of immunology, and a successful history of discovering and advancing novel therapies.
How much funding has Q32 Bio raised?
Q32 Bio has raised $168M across 4 rounds on record. The most recent is an undisclosed round of $55.0M announced in May 2026.
When did Q32 Bio last raise funding?
Q32 Bio's most recent funding round on record is an undisclosed round of $55.0M, announced in May 2026.
Who founded Q32 Bio?
FundedIQ lists Hong Wu (Founder), Shelia Violette (Founder) at Q32 Bio.
Who is the CEO of Q32 Bio?
Michael Broxson is listed as CEO at Q32 Bio.
Where is Q32 Bio headquartered?
Q32 Bio is based in Cambridge, Massachusetts, United States.
How many employees does Q32 Bio have?
Q32 Bio is in the 11-50 employee band.
How does Q32 Bio's funding compare to other Biotechnology startups?
Q32 Bio's latest round of $55.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Q32 Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Q32 Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.